Despite Democrats’ Celebratory Mood, It’s A Sad Day For American Patients.

Health pina messina kfJkpeI6Lgc unsplash

Democrats laud these price controls, which they glibly dub “negotiations,” as a way to lower drug costs for seniors on Medicare. But in the not-too-distant future, people of all ages may look back and rue this day—as the beginning of the end of America’s medical golden age.

President Joe Biden celebrated a milestone today—but American patients have no reason to cheer.

The White House announced the first 10 prescription drugs that, starting in 2026, will be subject to price controls authorized by the Inflation Reduction Act . . .

It’s laudable that lawmakers want to reduce out-of-pocket drug prices for seniors. But the tradeoffs inherent in price controls make them a brutal way to achieve this goal.  Without access to recently approved medicines or R&D dollars to bring miracle drugs to market, U.S. patients who otherwise would survive, instead will die.

Read the full article at Forbes

Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.

Subscribe to our newsletter:

This field is for validation purposes and should be left unchanged.
Scroll to Top